Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

References for PMC Articles for PubMed (Select 21297632)

1.

Treating childhood acute lymphoblastic leukemia without cranial irradiation.

Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV.

N Engl J Med. 2009 Jun 25;360(26):2730-41. doi: 10.1056/NEJMoa0900386.

2.

Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.

Yang JJ, Cheng C, Yang W, Pei D, Cao X, Fan Y, Pounds SB, Neale G, TreviƱo LR, French D, Campana D, Downing JR, Evans WE, Pui CH, Devidas M, Bowman WP, Camitta BM, Willman CL, Davies SM, Borowitz MJ, Carroll WL, Hunger SP, Relling MV.

JAMA. 2009 Jan 28;301(4):393-403. doi: 10.1001/jama.2009.7.

3.

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

Borowitz MJ, Devidas M, Hunger SP, Bowman WP, Carroll AJ, Carroll WL, Linda S, Martin PL, Pullen DJ, Viswanatha D, Willman CL, Winick N, Camitta BM; Children's Oncology Group.

Blood. 2008 Jun 15;111(12):5477-85. doi: 10.1182/blood-2008-01-132837. Epub 2008 Apr 3.

4.

Estimating local ancestry in admixed populations.

Sankararaman S, Sridhar S, Kimmel G, Halperin E.

Am J Hum Genet. 2008 Feb;82(2):290-303. doi: 10.1016/j.ajhg.2007.09.022.

5.

A genomewide admixture mapping panel for Hispanic/Latino populations.

Mao X, Bigham AW, Mei R, Gutierrez G, Weiss KM, Brutsaert TD, Leon-Velarde F, Moore LG, Vargas E, McKeigue PM, Shriver MD, Parra EJ.

Am J Hum Genet. 2007 Jun;80(6):1171-8. Epub 2007 Apr 20.

6.

Principal components analysis corrects for stratification in genome-wide association studies.

Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D.

Nat Genet. 2006 Aug;38(8):904-9. Epub 2006 Jul 23.

PMID:
16862161
7.

Treatment of acute lymphoblastic leukemia.

Pui CH, Evans WE.

N Engl J Med. 2006 Jan 12;354(2):166-78. Review. No abstract available.

PMID:
16407512
8.

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.

Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk BI, Howard SC, Hudson MM, Cheng C, Kun LE, Raimondi SC, Behm FG, Downing JR, Relling MV, Evans WE; Total Therapy Study XIIIB at St Jude Children's Research Hospital.

Blood. 2004 Nov 1;104(9):2690-6. Epub 2004 Jul 13.

9.
10.

Race and outcome in childhood acute lymphoblastic leukemia.

Carroll WL.

JAMA. 2003 Oct 15;290(15):2061-3. No abstract available.

PMID:
14559962
11.

Survival variability by race and ethnicity in childhood acute lymphoblastic leukemia.

Kadan-Lottick NS, Ness KK, Bhatia S, Gurney JG.

JAMA. 2003 Oct 15;290(15):2008-14.

PMID:
14559954
12.

Results of therapy for acute lymphoblastic leukemia in black and white children.

Pui CH, Sandlund JT, Pei D, Rivera GK, Howard SC, Ribeiro RC, Rubnitz JE, Razzouk BI, Hudson MM, Cheng C, Raimondi SC, Behm FG, Downing JR, Relling MV, Evans WE.

JAMA. 2003 Oct 15;290(15):2001-7.

PMID:
14559953
13.

Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.

Hutchinson RJ, Gaynon PS, Sather H, Bertolone SJ, Cooper HA, Tannous R, Wells LM, Heerema NA, Sailer S, Trigg ME; Children's Cancer Group/Children's Oncology Group.

J Clin Oncol. 2003 May 1;21(9):1790-7.

PMID:
12721256
14.

Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.

Bhatia S, Sather HN, Heerema NA, Trigg ME, Gaynon PS, Robison LL.

Blood. 2002 Sep 15;100(6):1957-64.

15.

Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.

Lange BJ, Bostrom BC, Cherlow JM, Sensel MG, La MK, Rackoff W, Heerema NA, Wimmer RS, Trigg ME, Sather HN; Children's Cancer Group.

Blood. 2002 Feb 1;99(3):825-33.

16.

Model-based clustering and data transformations for gene expression data.

Yeung KY, Fraley C, Murua A, Raftery AE, Ruzzo WL.

Bioinformatics. 2001 Oct;17(10):977-87.

17.

Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies.

Gaynon PS, Bostrom BC, Hutchinson RJ, Lange BJ, Nachman JB, Steinherz PG, Sensel MG, Lee MK, Stram DO, Sather HN.

J Clin Oncol. 2001 Apr 1;19(7):1916-25.

PMID:
11283123
18.

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

Coustan-Smith E, Sancho J, Hancock ML, Boyett JM, Behm FG, Raimondi SC, Sandlund JT, Rivera GK, Rubnitz JE, Ribeiro RC, Pui CH, Campana D.

Blood. 2000 Oct 15;96(8):2691-6.

19.

Inference of population structure using multilocus genotype data.

Pritchard JK, Stephens M, Donnelly P.

Genetics. 2000 Jun;155(2):945-59.

20.

Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.

Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W, Niemeyer C, Henze G, Feldges A, Zintl F, Kornhuber B, Ritter J, Welte K, Gadner H, Riehm H.

Blood. 2000 Jun 1;95(11):3310-22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk